- Lower volatility than the market (beta 0.25)
- Highly efficient cash conversion (100% FCF/OCF ratio)
- Established player in the Healthcare sector
Big movements in Pasithea Therapeutics Corp. stock price on Monday moving 103.33% between high and low
(Updated on Jun 22, 2026)
The Pasithea Therapeutics Corp. stock price gained 17.24% on the last trading day (Monday, 22nd Jun 2026), rising from $0.0058 to $0.0068. During the last trading day the stock fluctuated 103.33% from a day low at $0.0060 to a day high of $0.0122. The price has risen in 5 of the last 10 days and is up by 38.78% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 18 thousand more shares were traded than the day before. In total, 19 thousand shares were bought and sold for approximately $129.45 .
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -34.61% during the next 3 months and, with a 90% probability hold a price between $0.0016 and $0.0078 at the end of this 3-month period.
KTTAW Signals & Forecast
The Pasithea Therapeutics Corp. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $0.0063 and $0.0066. A breakdown below any of these levels will issue sell signals. Pasithea Therapeutics Corp. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, June 04, 2026, and so far it has fallen -37.61%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Pasithea Therapeutics Corp. stock
On the downside, the stock finds support just below today's level from accumulated volume at $0.0061 and $0.0056. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Pasithea Therapeutics Corp. finds support just below today's level at $0.0061. If this is broken, then the next support from accumulated volume will be at $0.0056 and $0.0052.
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0062 between high and low, or 103.33%. For the last week, the stock has had daily average volatility of 24.83%.
Our recommended stop-loss: $0.0064 (-6.02%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 11 days ago.)
Trading Expectations (KTTAW) For The Upcoming Trading Day Of Tuesday 23rd
For the upcoming trading day on Tuesday, 23rd we expect Pasithea Therapeutics Corp. to open at $0.0083, and during the day (based on 14 day Average True Range), to move between $0.0052 and $0.0084, which gives a possible trading interval of +/-$0.0032 (+/-60.69%) up or down from last closing price. If Pasithea Therapeutics Corp. takes out the full calculated possible swing range there will be an estimated 60.69% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $0.0072 (5.88%) than the support at $0.0061 (10.29%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Pasithea Therapeutics Corp. stock A Buy?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.
Current score:
1.369
Buy Candidate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on June 23, 2026 - $0.0083 ( 22.55%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
KTTAW Performance
Trading levels for KTTAW
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.0145 | 113.73% |
| R2 | 0.0122 | 78.90% |
| R1 | 0.0107 | 57.38% |
| Price | 0.0068 | |
| S1 | 0.0060 | -12.28% |
| S2 | 0.0045 | -33.80% |
| S3 | 0.0021 | -68.63% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.0079 | 16.18% |
| R2 | 0.0076 | 11.76% |
| R1 | 0.0072 | 5.88% |
| Price | 0.0068 | |
| S1 | 0.0061 | -10.29% |
| S2 | 0.0056 | -17.65% |
| S3 | 0.0052 | -23.53% |
FAQ
Click here for our free guide on how to buy Pasithea Therapeutics Corp. Stock.
Buy KTTAW